Search

everythinglearnresearchcommunity

for

Search:↓

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

Multiple treatments work best for hair loss.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

AR gene not major factor in female hair loss; different from male hair loss.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Balding men have higher heart disease risk.